Skip to main content

Peer Review reports

From: Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

Original Submission
5 Sep 2006 Submitted Original manuscript
23 Sep 2006 Reviewed Reviewer Report - Robert Pirker
24 Sep 2006 Reviewed Reviewer Report - Andrea Mancuso
26 Sep 2006 Reviewed Reviewer Report - Tim Littlewood
27 Nov 2006 Reviewed Reviewer Report - Allan Donner
20 Dec 2006 Author responded Author comments - Vera Hirsh
Resubmission - Version 2
20 Dec 2006 Submitted Manuscript version 2
12 Jan 2007 Reviewed Reviewer Report - Andrea Mancuso
16 Jan 2007 Reviewed Reviewer Report - Allan Donner
Resubmission - Version 3
Submitted Manuscript version 3
14 Feb 2007 Author responded Author comments - Vera Hirsh
Resubmission - Version 4
14 Feb 2007 Submitted Manuscript version 4
Publishing
6 Mar 2007 Editorially accepted
6 Mar 2007 Article published 10.1186/1745-6215-8-8

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215